These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 13416857

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Chlorpromazine and reserpine after insulin shock therapy in schizophrenia].
    CARRIE J, FOURNY L, GAYRAL L, HERVE Y.
    Encephale; 1956; 45(4):663-7. PubMed ID: 13384280
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Study of the differential behavioral effects of reserpine, chlorpromazine, and a combination of these drugs in chronic schizophrenic patients.
    BARRETT WW, ELLSWORTH RB, CLARK LD, ENNISS J.
    Dis Nerv Syst; 1957 Jun; 18(6):209-15. PubMed ID: 13427660
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of chlorpromazine and reserpine on sedation and convulsive thresholds in schizophrenic patients.
    BRADLEY PB, JEAVONS PM.
    Electroencephalogr Clin Neurophysiol; 1957 Nov; 9(4):661-72. PubMed ID: 13480239
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of drug-resistive chronic schizophrenics.
    MEAD BT, ELLSWORTH RB, GRIMMETT JO.
    J Nerv Ment Dis; 1958 Oct; 127(4):351-8. PubMed ID: 13599041
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prediction of the response of chronic schizophrenics to drug therapy: a preliminary report on the relationship between palmar sweat and the behaviorial effects of tranquilizing drugs.
    CLARK LD, ELLSWORTH RB.
    J Clin Psychol; 1957 Jan; 13(1):59-61. PubMed ID: 13385356
    [No Abstract] [Full Text] [Related]

  • 15. [Factor analysis in clinicotherapeutic researches. I. Factor analysis; its fundamentals & practical applications; method of central approach. II. Application of factor analysis in a group of schizophrenics after treatments of various types].
    NICOLETTI I, MAGHERINI G.
    Rass Studi Psichiatr; 1957 Jan; 46(6):903-33. PubMed ID: 13527751
    [No Abstract] [Full Text] [Related]

  • 16. Iproniazid and combined iproniazid-reserpine treatment of depressive and inactive patients.
    RASMUSSEN EB, KRISTJANSEN P.
    Acta Psychiatr Scand Suppl; 1959 Jan; 34(136):98-100. PubMed ID: 14436356
    [No Abstract] [Full Text] [Related]

  • 17. Effects of chlorpromazine and reserpine in chronic schizophrenic patients.
    FREEMAN H, ARNOLD AL, CLINE HS.
    Dis Nerv Syst; 1956 Jul; 17(7):213-9. PubMed ID: 13330613
    [No Abstract] [Full Text] [Related]

  • 18. Chlorpromazine and reserpine in the treatment of psychoses.
    KINROSS-WRIGHT V.
    Ann N Y Acad Sci; 1955 Apr 15; 61(1):174-82. PubMed ID: 14377285
    [No Abstract] [Full Text] [Related]

  • 19. Clinical use of reserpine in psychiatry: comparison with chlorpromazine.
    BLEULER M, STOLL WA.
    Ann N Y Acad Sci; 1955 Apr 15; 61(1):167-73. PubMed ID: 14377284
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.